You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LEN03T

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Overall Survival in Unresectable Hepatocellular Carcinoma

Completed
  • Carcinoma, Hepatocellular
  • +3 more
  • Osaka, Japan
  • +1 more
Mar 7, 2022

Advanced Solid Tumor, Cutaneous T Cell Lymphoma Trial in Guanzhou (SIM1811-03)

Recruiting
  • Advanced Solid Tumor
  • Cutaneous T Cell Lymphoma
  • Guanzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Mar 10, 2023

Advanced Solid Tumor, Cutaneous T-cell Lymphoma (CTCL) Trial in United States (SIM1811-03)

Recruiting
  • Advanced Solid Tumor
  • Cutaneous T-cell Lymphoma (CTCL)
  • Detroit, Michigan
  • +5 more
Oct 6, 2022

Solid Tumor Trial in Shanghai (Neo-T, Cyclophosphamide, Fludarabine)

Recruiting
  • Solid Tumor
  • Neo-T
  • +3 more
  • Shanghai, China
  • +1 more
Mar 23, 2023

Protocol CAUSE-03 / CHEETAH

Not yet recruiting
  • Asthma
    • Aurora, Colorado
    • +6 more
    Nov 15, 2023

    CD 19+ Acute Leukemia Trial in Seattle (T-cell Antigen Presenting Cells expressing truncated CD19 (T-APC))

    Active, not recruiting
    • CD 19+ Acute Leukemia
    • T-cell Antigen Presenting Cells expressing truncated CD19 (T-APC)
    • Seattle, Washington
      Seattle Children's Hospital
    Mar 22, 2022

    enVista Toric 0.9D Intraocular Lenses

    Recruiting
    • Corneal Astigmatism
    • enVista Toric
    • enVista non-Toric (spherical)
    • Calgary, Alberta, Canada
    • +2 more
    Nov 9, 2022

    HIV-1 Infection Trial in United States (Oral Lenacapavir, Subcutaneous Lenacapavir, Teropavimab)

    Active, not recruiting
    • HIV-1 Infection
    • Oral Lenacapavir
    • +3 more
    • Los Angeles, California
    • +22 more
    Nov 4, 2022

    Serious Cardiac Events in Postpartum Women

    Completed
    • Ventricular Tachyarrhythmia
    • +3 more
    • Montreal, Quebec, Canada
      Lady Davis Institute for Medical Research, Jewish General Hospit
    Jul 2, 2021

    Multiple Myeloma in Relapse, Multiple Myeloma Progression, Multiple Myeloma Stage II Trial in London (Rivaroxaban, ASA)

    Recruiting
    • Multiple Myeloma in Relapse
    • +5 more
    • London, Ontario, Canada
      London Health Sciences Centre
    Oct 3, 2022

    Brodalumab in Plaque Psoriasis to Understand Impact on Quality

    Recruiting
    • Psoriasis
    • Brodalumab
    • Matched cohort
    • Calgary, Alberta, Canada
    • +33 more
    Oct 8, 2022

    Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, MK-4830, Belzutifan)

    Recruiting
    • Carcinoma, Renal Cell
    • Pembrolizumab
    • +5 more
    • New Haven, Connecticut
    • +38 more
    Jan 25, 2023

    Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Favezelimab/Pembrolizumab, Belzutifan)

    Recruiting
    • Carcinoma, Renal Cell
    • Pembrolizumab
    • +5 more
    • New Haven, Connecticut
    • +37 more
    Jan 25, 2023

    Arm Injury Trial in Pécs (Lidocaine brachial plexus block, Bupivacaine brachial plexus block, Mixture brachial plexus block)

    Enrolling by invitation
    • Arm Injury
    • Lidocaine brachial plexus block
    • +2 more
    • Pécs, Baranya, Hungary
      University of Pécs, Medical School
    Jul 21, 2021

    Ulcerative Colitis Trial in Worldwide (drug, other, combination product)

    Completed
    • Ulcerative Colitis
    • AMT-101 (oral)
    • +2 more
    • Tbilisi, Georgia
    • +17 more
    Sep 13, 2022

    Hydrochlorothiazide and Risk of Skin Cancer

    Completed
    • Non-melanoma Skin Cancer
    • +2 more
    • Montreal, Quebec, Canada
      Centre for Clinical Epidemiology, Lady Davis Institute, Jewish G
    Mar 8, 2021

    Amyotrophic Lateral Sclerosis Trial in Canada, United States (ANX005)

    Recruiting
    • Amyotrophic Lateral Sclerosis
    • Phoenix, Arizona
    • +10 more
    Jul 1, 2022

    Hepatocellular Carcinoma Trial in Shanghai (PD-1 and Lenvatinib Plus TACE)

    Recruiting
    • Hepatocellular Carcinoma
    • PD-1 and Lenvatinib Plus TACE
    • Shanghai, Shanghai, China
      Huashan hospital
    Aug 16, 2022

    Diabetes Trial in United States (CLBS03 Low Dose, CLBS03 High Dose, Placebo)

    Completed
    Has Results
    • Diabetes Mellitus
    • CLBS03 Low Dose
    • +2 more
    • San Diego, California
    • +14 more
    Dec 14, 2020

    Colo-rectal Cancer Trial in Worldwide (Arfolitixorin, Leucovorin)

    Active, not recruiting
    • Colo-rectal Cancer
    • Gilbert, Arizona
    • +93 more
    Mar 29, 2022

    Lenvatinib Mesylate in Unresectable Thyroid Cancer

    Completed
    • Thyroid Neoplasms
    • Osaka, Japan
    • +1 more
    Jan 7, 2020

    Myocardial Infarction, Acute Trial in Poland (Ferinject, Sodium Chloride 0.9% Inj)

    Recruiting
    • Myocardial Infarction, Acute
    • Wrocław, Dolnośląskie, Poland
    • +14 more
    Feb 24, 2023

    Multiple Myeloma Trial in Hackensack (Daratumumab, Pomalidomide, All-trans retinoic acid)

    Recruiting
    • Multiple Myeloma
    • Hackensack, New Jersey
      John Theurer Cancer Center
    Jun 10, 2022

    Hepatitis B, Chronic Trial in Worldwide (EYP001a, Placebo, Entecavir)

    Active, not recruiting
    • Hepatitis B, Chronic
    • Brisbane, Australia
    • +17 more
    May 12, 2021

    MDS Trial in Beijing (Lenalidomide, Azacitidine)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Beijing, China
      Peking union medical college hospital
    Aug 16, 2023